Advertisement

Topics

Companies Related to "Mediators of Social Support in Coronary Disease" [Most Relevant Company Matches] RSS

07:43 EST 17th February 2019 | BioPortfolio

Here are the most relevant search results for "Mediators of Social Support in Coronary Disease" found in our extensive corporate database of over 50,000 company records.

Showing "Mediators Social Support Coronary Disease" Companies 1–25 of 6,300+

Relevant

PlaqueTec Ltd.

PlaqueTec offers a first-of-its-kind catheter technology for cardiologists to routinely assess inflammation in the coronary artery, and better understand residual inflammatory risk. It has been proven to detect inflammatory molecules across the site of coronary artery disease (CAD), and can discriminate between patients with greater and lesser levels of co...


Rcadia Medical Imaging Ltd.

Rcadia Medical Imaging develops and markets automated image processing software products for blood vessel analysis in patients with suspected cardiovascular disease. The company's first FDA-cleared product, the COR Analyzer® System, provides fully automated analysis of Coronary CT angiography to enable the practical application of cCTA in detecting severe coronary artery disease. The COR Analyzer...

Cappella, Inc.

Cappella, Inc. is a medical device company, developing novel solutions for the treatment of complex Coronary Artery Disease (CAD), specifically bifurcation disease. Cappella’s initial product, the Sideguard® Coronary Sidebranch Stent & Delivery System offers interventional cardiologists a straightforward, effective solution that focuses on treating...


Cappella Inc.

Cappella, Inc. is a medical device company, developing novel solutions for the treatment of complex Coronary Artery Disease (CAD) and specifically bifurcation vascular disease. Cappella's initial product, the Sideguard® Coronary Sidebranch Stent & Delivery System offers interventional cardiologists a straightforward, effective solution that focuses on treating the sidebranch of diseased coronary ...

Rcadia Medical Imaging

Rcadia Medical Imaging develops and markets automated image processing software products for blood vessel analysis in patients with suspected cardiovascular disease. The company's first FDA-cleared product, the COR Analyzer® System, provides fully automated, real-time analysis of Coronary CT angiography to enable the practical application of cCTA in detecting severe coronary artery disease. The C...

Rcadia Medical Imaging, Ltd.

Rcadia Medical Imaging develops and markets automated image processing software products for blood vessel analysis in patients with suspected cardiovascular disease. The company's first FDA-cleared product, the COR Analyzer® System, provides fully automated, real-time analysis of Coronary CT angiography to enable the practical application of cCTA in detecting severe coronary artery disease. The C...

Satori Pharmaceuticals Incorporated

Satori Pharmaceuticals is committed to the development of disease modifying therapies for Alzheimer's disease through innovative approaches that selectively target the key neurotoxic mediators and pathways of this debilitating neurodegenerative disorder.

InfraReDx, Inc.

InfraReDx, Inc., headquartered in Burlington, Massachusetts, is a privately-funded medical device company founded in 1998 and focused on intravascular characterization of disease in the coronary arteries. InfraReDx is the maker of the LipiScan(TM) system, a novel near-infrared (NIR) spectroscopy catheter that can detect the lipid core coronary plaques suspected to cause most heart attacks and know...

Complexa, Inc.

Complexa, Inc. is a platform biopharmaceutical company researching and developing endogenous human cell signaling technologies targeting an array of prevalent inflammatory and metabolic diseases. The company’s proprietary technology involves the synthesis and therapeutic applications of endogenous nitro-fatty acids (NFAs) and additional structure/func...

EPIXMedical Incorporated

EPIX's goal is to transform the management and diagnosis of vascular disease through the development of targeted MRI contrast agents. Based on its core, proprietary technology, EPIX is advancing its pipeline of products such as MS-325, the Company's lead MRI contrast agent currently in Phase III trials. MS-325 is also in development to help diagnose coronary artery disease, breast cancer, female s...

Cappella Medical Devices Limited

Cappella, Inc. develops novel solutions for the treatment of complex coronary artery disease (CAD) - specifically bifurcation disease. Cappella’s Sideguard® coronary sidebranch technology offers interventional cardiologists a straightforward, effective, solution that focuses on treating the sidebranch of diseased coronary arteries first, rather tha...

Cancer Support Community North Texas

The mission of Cancer Support Community North Texas (formerly Gilda’s Club) is to ensure that all people impacted by cancer are empowered by knowledge, strengthened by action, and sustained by community. The innovative program offered at Cancer Support Community North Texas is an essential complement to medical care, providing networking groups, works...

PLC Systems

PLC is a global leader in the development of products for performing a revolutionary new surgical procedure known as transmyocardial revascularization (TMR). TMR offers a completely new medical treatment option for patients who suffer from severe coronary artery disease. Coronary artery disease is the leading cause of death in the United States. Working with leading researchers and premier heart...

EPIX Medical Incorporated

Based on its core, proprietary technology, EPIX is advancing its pipeline of products such as MS-325, the Company's lead MRI contrast agent currently in Phase III trials. MS-325 is also in development to help diagnose coronary artery disease, breast cancer, female sexual arousal dysfunction, atherosclerosis and myocardial perfusion. In addition to MS-325, EPIX's pipeline includes a new class of MR...

Cappella Medical Devices Ltd

Cappella, Inc. is a medical device company that develops novel solutions for the treatment of complex coronary artery disease (CAD) focused on protecting the coronary sidebranch arteries. Cappella’s Sideguard® coronary sidebranch technology offers interventional cardiologists a straightforward, effective, and easy to use solution that preserves the ...

Rodaris Pharmaceuticals Limited

The Company has had unparalleled success in unravelling the biochemistry and chemistry of small molecules that mediate the individual signalling events of hormones and growth factors. It has produced novel libraries of synthetic mediators which offer exciting new therapeutic targets for treatment of a wide range of endocrine, immunological, cardiovascular and neurological disease.

Cappella Medical Devices, Ltd.

Cappella, Inc. is a medical device company, developing novel solutions for the treatment of complex Coronary Artery Disease (CAD) and specifically bifurcation vascular disease. Cappella’s initial product, the Sideguard® Coronary Sidebranch Stent & Delivery System offers interventional cardiologists a straightforward, effective solution that focuses...

The Social Express

Launched in 2011, The Social Express is an interactive program that supports social and emotional learning for students struggling with Autism Spectrum Disorders (ASD), ADHD, and other social learning challenges. Available to schools, professionals, and parents, the award-winning online program teaches users how to think about and manage social situations,...

diaDexus

diaDexus, a privately held biotechnology company, is focused on the discovery, development, and commercialization of novel, patent protected diagnostic products with high clinical value.diaDexus’ lead product, the PLAC® test, is a blood test that measures the concentration of lipoprotein-associated phospholipase A2 (Lp-PLA2), a novel risk factor for coronary heart disease and ischemic stroke. T...

hope2day, Limited

The charity’s vision is to support, educate and empower the lives of people in need with meaningful, lasting impact. hope2day develops programs to support, children, families, the elderly and indigenous people who live with chronic disease, disability, poverty, homelessness and social or financial disadvantage,. hope2day is a registered Australian Pub...

Susan G. Komen and Pfizer

Susan G. Komen is the world's largest breast cancer organization, funding more breast cancer research than any other nonprofit outside of the federal government while providing real-time help to those facing the disease. Komen has set a Bold Goal to reduce the current number of breast cancer deaths by 50 percent in the U.S. by 2026. Since its founding in 1...

Novogen

Novogen's business is in the most pressing area facing medicine in the modern era - that of degenerative diseases and disorders. Cancer Heart disease (stroke, hypertension, coronary artery disease) Osteoporosis Rheumatoid arthritis Inflammatory Bowel Disease (ulcerative colitis, Crohn's Disease) Neurological diseases (Parkinson's Disease, motor neurone disease) Autoimmune diseases (m...

Susan G. Komen and Manduka

Susan G. Komen is the world’s largest breast cancer organization, funding more breast cancer research than any other nonprofit outside of the federal government while providing real-time help to those facing the disease. Komen has set a Bold Goal to reduce the current number of breast cancer deaths by 50 percent in the U.S. by 2026. Since its founding...

CathWorks

CathWorks is a medical technology company focused on applying its advanced computational science platform to optimize PCI therapy decisions and elevate coronary angiography from visual assessment to an objective FFR-based decision-making tool for physicians. FFR-guided PCI decision-making is proven to provide significant clinical benefits for patients with...

Sport and Social Industry Association

The Sport and Social Industry Association is a non-profit trade organization for businesses that produce and manage various adult sport leagues and social events. The organization was founded in 2011 and developed by the industry as a whole, after many years of frustration and outdated business practices. The SSIA was organized as a non-profit to allow for...


More From BioPortfolio on "Mediators of Social Support in Coronary Disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks